Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-04-15 @ 3:17 PM
Study NCT ID:
NCT01981161
Status:
COMPLETED
Last Update Posted:
2020-08-25
First Post:
2013-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis
Sponsor:
University Hospital, Toulouse
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1235207
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |